Edwin Rock
2023
In 2023, Edwin Rock earned a total compensation of $1.2M as Chief Medical Officer and Senior Vice President at GlycoMimetics.
Compensation breakdown
| Non-Equity Incentive Plan | $198,779 |
|---|---|
| Option Awards | $474,912 |
| Salary | $466,620 |
| Other | $12,000 |
| Total | $1,152,311 |
Rock received $474.9K in option awards, accounting for 41% of the total pay in 2023.
Rock also received $198.8K in non-equity incentive plan, $466.6K in salary and $12K in other compensation.
Rankings
In 2023, Edwin Rock's compensation ranked 1,054th out of 2,983 executives tracked by ExecPay. In other words, Rock earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,054 out of 2,983 | 65th |
Division Manufacturing | 626 out of 1,637 | 62nd |
Major group Chemicals And Allied Products | 429 out of 906 | 53rd |
Industry group Drugs | 418 out of 869 | 52nd |
Industry Pharmaceutical Preparations | 286 out of 627 | 54th |
Source: SEC filing on April 1, 2024.
Rock's colleagues
We found two more compensation records of executives who worked with Edwin Rock at GlycoMimetics in 2023.